CytomX Therapeutics EPS Diluted from Discontinued Operations (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.58 +0.15 (+2.76%) USD | NASDAQ | Feb 23, 16:00

5.54 -0.04 (-0.72%) Pre-Market: 19:59

View EPS Diluted from Discontinued Operations (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--